3MSS PDB NFT

Abl kinase in complex with imatinib and fragment (FRAG2) in the myristate site

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba

IPFS of NFT metadata:

bafybeiake4ce2jiqpfinilw47pv3n2fb4wqp5dflwiax6nnz3eqwcarrga/metadata.json

IPFS of structure file:

bafybeibtdiqjyletkwitjcxvffxdabagh4t5qnf5a4en7mkx7xwv6ykdwq/3mss.pdb

MOLNFT 3MSS research and analysis (ICN3D with VR)

FASTA sequences

>3mss_A mol:protein length:293 Tyrosine-protein kinase ABL1
GAMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRGT
>3mss_B mol:protein length:293 Tyrosine-protein kinase ABL1
GAMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRGT
>3mss_C mol:protein length:293 Tyrosine-protein kinase ABL1
GAMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRGT
>3mss_D mol:protein length:293 Tyrosine-protein kinase ABL1
GAMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRGT

References and links

Current molecular structure file and data about current molecular structure file and NFT token based on it with
PDBID: 3MSS
TITLE: Abl kinase in complex with imatinib and fragment (FRAG2) in the myristate site
DOI: 10.1021/ja101837n
AUTHORS: Cowan-Jacob, S.W., Rummel, G., Fendrich, G.
ACCESSION DATE: 04/29/10
Obtained at RCSB PDB https://rcsb.org
RCSB Link: https://www.rcsb.org/structure/3MSS